SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
3.720
+0.060 (1.64%)
At close: Mar 6, 2026, 4:00 PM EST
3.790
+0.070 (1.88%)
After-hours: Mar 6, 2026, 4:10 PM EST
SBC Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for SBC stock has a target of 8.00, which predicts a 115.05% increase from the current stock price of 3.72.
Price Target: $8.00 (+115.05%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for SBC is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 |
|---|---|
| Strong Buy | 1 |
| Buy | 0 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +115.05% | Mar 6, 2026 |
Financial Forecast
Revenue This Year
181.03M
from 205.42M
Decreased by -11.87%
Revenue Next Year
193.29M
from 181.03M
Increased by 6.77%
EPS This Year
0.45
from 0.48
Decreased by -7.25%
EPS Next Year
0.50
from 0.45
Increased by 11.65%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 191.9M | 204.0M | |
| Avg | 181.0M | 193.3M | |
| Low | 173.9M | 185.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -6.6% | 12.7% | |
| Avg | -11.9% | 6.8% | |
| Low | -15.4% | 2.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.51 | 0.53 | |
| Avg | 0.45 | 0.50 | |
| Low | 0.37 | 0.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.6% | 17.2% | |
| Avg | -7.2% | 11.7% | |
| Low | -22.9% | 7.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.